BETAHISTINE GxP betahistine dihydrochloride 16 mg tablets blister packs

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

betahistine dihydrochloride, Quantity: 16 mg

Saatavilla:

Arrotex Pharmaceuticals Pty Ltd

INN (Kansainvälinen yleisnimi):

betahistine dihydrochloride

Lääkemuoto:

Tablet, uncoated

Koostumus:

Excipient Ingredients: purified talc; mannitol; microcrystalline cellulose; citric acid; colloidal anhydrous silica

Antoreitti:

Oral

Kpl paketissa:

10 tablets, 30 tablets, 60 tablets, 100 tablets, 25 tablets

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

Meniere's Syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

Tuoteyhteenveto:

Visual Identification: Uncoated, round, biconvex, white to light creamy tablets, with a groove on one surface.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Valtuutuksen tilan:

Licence status A

Valtuutus päivämäärä:

2014-08-14